Biotechnology Assets, S.A. (BME: BST)
Spain
· Delayed Price · Currency is EUR 0.303
+0.008 (2.54%)
Dec 18, 2024, 5:21 PM CET
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €18.78 million as of December 20, 2024. Its market cap has decreased by -21.60% in one year.
Market Cap
18.78M
Enterprise Value
20.44M
Revenue
3.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.30
Market Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 18.78M, a decrease of -74.84%. That is a compound annual growth rate of -18.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols, S.A. | 5.75B |
| Laboratorios Farmaceuticos Rovi, S.A. | 3.14B |
| Pharma Mar, S.A. | 1.38B |
| Clínica Baviera, S.A. | 493.99M |
| Laboratorio Reig Jofre, S.A. | 205.75M |
| Pangaea Oncology, S.A. | 58.75M |